Vanguard Global Advisers
FLGT icon

Vanguard Global Advisers’s Fulgent Genetics FLGT Stock Holding History

Vanguard Global Advisers’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$177K Hold
8,602
– – ﹤0.01% 2552
2026
Q1 		$137K Buy
+8,602
New +$187K ﹤0.01% 2594

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Global Advisers's FLGT Position: Q2 2026 in Review

Vanguard Global Advisers held its Fulgent Genetics (FLGT) position steady in Q2 2026 at 8,602 shares worth $177K. The position accounts for ﹤0.01% of the portfolio, ranked #2552.

Vanguard Global Advisers first reported a position in FLGT in Q1 2026 and has held it in 2 quarters since. 140 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Vanguard Global Advisers held 8,602 shares of Fulgent Genetics worth $177K as of Q2 2026.
  • Vanguard Global Advisers left its Fulgent Genetics share count unchanged in Q2 2026.
  • Fulgent Genetics made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2552 holding.
  • Vanguard Global Advisers first reported a position in Fulgent Genetics in Q1 2026 and has held it in 2 quarters since.
  • 140 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.